Shengxiang Biotech announced that the company's product dengue virus and chikungunya virus nucleic acid detection kit recently received the “Medical Device Registration Certificate” issued by the State Drug Administration. The registration certificate is valid until August 16, 2031. This product is the first approved joint test product for dengue fever and chikungunya in China. It is a domestic third-class in vitro diagnostic reagent. It can detect two types of pathogens at the same time. The test period is about 90 minutes, and it is suitable for various testing scenarios.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.